Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Magid Lital"'
Autor:
Sigal Liraz-Zaltsman, Esther Shohami, Liat Avram, Raphael Mechoulam, Merav Elgali, Magid Lital, Sami Heymann, Yoram Cohen
Publikováno v:
Journal of Neurotrauma. 36:1836-1846
Cannabis is one of the most widely used plant drugs in the world today. In spite of the large number of scientific reports on medical marijuana, there still exists much controversy surroun...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::958aae902f89ce781df70c6cb1bdb345
https://doi.org/10.1089/neu.2018.6063
https://doi.org/10.1089/neu.2018.6063
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Horváth, Bėla1,2, Magid, Lital3, Mukhopadhyay, Partha1, Bátkai, Sándor1, Rajesh, Mohanraj1, Park, Ogyi4, Tanchian, Galin1, Gao, Rachel Y1, Goodfellow, Catherine E5, Glass, Michelle5, Mechoulam, Raphael4, Pacher, Pál1
Publikováno v:
British Journal of Pharmacology. Apr2012, Vol. 165 Issue 8, p2462-2478. 17p. 3 Color Photographs, 1 Chart, 11 Graphs.
Autor:
Bėla Horváth, Partha Mukhopadhyay, Rachel Y. Gao, Pal Pacher, Galin Tanchian, Magid Lital, Mohanraj Rajesh, Raphael Mechoulam, Michelle Glass, Ogyi Park, Sandor Batkai, Catherine E. Goodfellow
Publikováno v:
British Journal of Pharmacology. 165:2462-2478
BACKGROUND AND PURPOSE Cannabinoid CB2 receptor activation has been reported to attenuate myocardial, cerebral and hepatic ischaemia-reperfusion (I/R) injury. EXPERIMENTAL APPROACH We have investigated the effects of a novel CB2 receptor agonist ((1S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf195d2535e65f2adac3b4e44b078174
https://doi.org/10.1111/j.1476-5381.2011.01381.x
https://doi.org/10.1111/j.1476-5381.2011.01381.x
Publikováno v:
British Journal of Pharmacology. 163:1402-1410
Traumatic brain injury (TBI) represents the leading cause of death in young individuals. It triggers the accumulation of harmful mediators, leading to secondary damage, yet protective mechanisms are also set in motion. The endocannabinoid (eCB) syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43c7fe9d09c3c16a8db8e1b35ec8a1c7
https://doi.org/10.1111/j.1476-5381.2011.01343.x
https://doi.org/10.1111/j.1476-5381.2011.01343.x
Autor:
Magid, Lital, Heymann, Sami, Elgali, Merav, Avram, Liat, Cohen, Yoram, Liraz-Zaltsman, Sigal, Mechoulam, Raphael, Shohami, Esther
Publikováno v:
Journal of Neurotrauma; Jun2019, Vol. 36 Issue 11, p1836-1846, 11p
Autor:
Horváth, Bėla, Magid, Lital, Mukhopadhyay, Partha, Bátkai, Sándor, Rajesh, Mohanraj, Park, Ogyi, Tanchian, Galin, Gao, Rachel Y, Goodfellow, Catherine E, Glass, Michelle, Mechoulam, Raphael, Pacher, Pál
Cannabinoid CB(2) receptor activation has been reported to attenuate myocardial, cerebral and hepatic ischaemia-reperfusion (I/R) injury.We have investigated the effects of a novel CB(2) receptor agonist ((1S,4R)-2-(2,6-dimethoxy-4-(2-methyloctan-2-y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f065a52c5910a19f574a680fb853c25
https://europepmc.org/articles/PMC3423243/
https://europepmc.org/articles/PMC3423243/
Traumatic brain injury (TBI) represents the leading cause of death in young individuals. It triggers the accumulation of harmful mediators, leading to secondary damage, yet protective mechanisms are also set in motion. The endocannabinoid (eCB) syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e92947dad59fb955c89e7a3b25b8be56
https://europepmc.org/articles/PMC3165950/
https://europepmc.org/articles/PMC3165950/
Autor:
Horváth B, Magid L, Mukhopadhyay P, Bátkai S, Rajesh M, Park O, Tanchian G, Gao RY, Goodfellow CE, Glass M, Mechoulam R, Pacher P, Horváth, Bėla, Magid, Lital, Mukhopadhyay, Partha, Bátkai, Sándor, Rajesh, Mohanraj, Park, Ogyi, Tanchian, Galin, Gao, Rachel Y
Publikováno v:
British Journal of Pharmacology; Apr2012, Vol. 165 Issue 8, p2462-2478, 17p
Autor:
Shohami E; The Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Israel. esty@cc.huji.ac.il, Cohen-Yeshurun A, Magid L, Algali M, Mechoulam R
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2011 Aug; Vol. 163 (7), pp. 1402-10.